Yoshifumi Yamagishi
Yamaguchi University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoshifumi Yamagishi.
Diagnostic Microbiology and Infectious Disease | 1995
Hiroshi Miyawaki; Jiro Fujita; Keiichi Takigawa; Kiyoshi Negayama; Yoshifumi Yamagishi; Yasufumi Yamaji; Kazunobu Ouchi; Teruko Nakazawa; Koichi Kawanishi; Jiro Takahara
We used DNA fingerprinting by the arbitrarily primed polymerase chain reaction (AP-PCR) technique for an epidemiologic investigation of Pseudomonas cepacia nosocomial isolates obtained from patients attending our hospital. This approach was compared with conventional phenotypic typing and pulsed-field gel electrophoresis (PFGE). The patterns of gel electrophoresis of the products of AP-PCR differed significantly according to differences in the concentration of Mg2+ and in pH. AP-PCR and PFGE was identical in their resolving power, as the two methods generated four different profiles and identified the same group of strains. The AP-PCR method constitutes an easy alternative to the well-established PFGE method.
Journal of Alternative and Complementary Medicine | 2013
Takamasa Nishiuchi; Yuichi Okutani; Yoshifumi Yamagishi; Toshikazu Fujita; Osamu Imataki; Hiroaki Ohnishi; Takuya Matsunaga; Teruki Shimizu; Hiroshi Shimizu
This is the first report of the successful treatment of advanced biliary tract cancer with gemcitabine single-agent chemotherapy in combination with Juzen-taiho-to (JTT), a Japanese traditional herbal medicine. An 84-year-old woman was referred to our hospital with general fatigue and appetite loss; she was diagnosed with advanced biliary tract cancer and accompanying colonic invasion and hepatic metastasis. The patients response to combination chemotherapy was extremely good, and her tumors disappeared. Recent studies have confirmed the occurrence of spontaneous and induced antitumor immune responses, carried out by tumor-infiltrating lymphocytes in the tumor microenvironment. The availability, antigen presentation, and proliferation of these immune cells are increased by cytokines such as granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-2. Recently, JTT has gained recognition as a biological response modifier that has stimulatory effects on systemic immune responses such as enhancement of cytokine expression (GM-CSF, IL-2, etc.). In addition, some chemotherapy agents, such as anthracyclines and gemcitabine, are effective boosters of the immune response through tumor-specific antigen overexpression after apoptotic tumor cell destruction. These findings suggest that JTT enhances the antitumor effects of gemcitabine, in particular its tumor-specific effects on immune response, and these drugs are a good combination for advanced biliary tract cancer therapy.
The Journal of the Japanese Association for Infectious Diseases | 1993
Keiichi Takigawa; Jiro Fujita; Kiyoshi Negayama; Yoshifumi Yamagishi; Yasufumi Yamaji; Ouchi K; Yamada K; Mitsuko Abe; Teruko Nakazawa; Koichi Kawanishi
Chest | 1993
Yoshifumi Yamagishi; Jiro Fujita; Keiichi Takigawa; Kiyoshi Negayama; Teruko Nakazawa; Jiro Takahara
Chest | 1992
Jiro Fujita; Hiroyuki Nakamura; Yoshifumi Yamagishi; Yasufumi Yamaji; Taiichi Shiotani; Shozo Irino
Journal of Antimicrobial Chemotherapy | 1992
Jiro Fujita; Kiyoshi Negayama; Keiichi Takigawa; Yoshifumi Yamagishi; Akihito Kubo; Yasufumi Yamaji; Jiro Takahara
Chest | 1993
Jiro Fujita; Yoshifumi Yamagishi; Akihito Kubo; Keiichi Takigawa; Yasufumi Yamaji; Jiro Takahara
Chest | 1994
Jiro Fujita; Ichiro Yamadori; Yasufumi Yamaji; Yoshifumi Yamagishi; Keiichi Takigawa; Jiro Takahara
Journal of Antimicrobial Chemotherapy | 1995
Keiichi Takigawa; Jiro Fujita; Kiyoshi Negayama; Guang Xu; Yoshifumi Yamagishi; Hiroshi Miyawaki; Satoko Hojo; Yasufumi Yamaji; Jiro Takahara
Journal of Antimicrobial Chemotherapy | 1993
Jiro Fujita; Kiyoshi Negayama; Keiichi Takigawa; Yoshifumi Yamagishi; Yasufumi Yamaji; Koichi Kawanishi; Jiro Takahara